Epigenomics AG NA buy papaver
Start price
26.06.18
/
50%
€2.25
Target price
26.12.18
€3.15
Performance (%)
-16.49%
End price
26.12.18
€1.76
Summary
This prediction ended on 26.12.18 with a price of €1.76. The price of Epigenomics AG NA has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.49%. papaver has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Epigenomics AG NA | - | - | - | - |
iShares Core DAX® | -0.654% | 1.989% | 14.984% | 18.052% |
iShares Nasdaq 100 | 0.903% | 5.664% | 36.140% | 58.351% |
iShares Nikkei 225® | -0.740% | -1.363% | 10.792% | 6.321% |
iShares S&P 500 | -0.013% | 3.020% | 28.126% | 48.476% |
Comments by papaver for this prediction
In the thread Epigenomics AG NA diskutieren
Günstig
Vor dem Übernahmeversuch stand der Aktienkurs bei +/-- 5,00 Euro.
Inzwischen ist der Test Epicolon in Amerika eingeführt und mit einem Medikament gegen Lungenkrebs kommt die Firma gut voran.
(Laufzeit überschritten)